Need professional-grade analysis? Visit stockanalysis.com
$48.12B
79.52
7,676
0.21%
GDERF (GDERF) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at $205.15, down 2.31% from the previous close.
Over the past year, GDERF has traded between a low of $120.00 and a high of $225.85. The stock has gained 71.0% over this period. It is currently 9.2% below its 52-week high.
GDERF has a market capitalization of $48.12B, with a price-to-earnings ratio of 79.52 and a dividend yield of 0.21%.
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Side-by-side comparison against top Healthcare peers.